• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Abstract 271: Anti-coagulation and Ischemic Stroke Risk in Patients with Chronic Kidney Disease and Atrial Fibrillation: Insights from the Kaiser Permanente Colorado Atrial Fibrillation Registry Session Title: Poster Session II
Conclusion: 1 in 3 patients with atrial fibrillation have CKD. There were similar reductions in the risk of stroke associated with warfarin use for CKD and non-CKD patients. These findings reinforce current clinical practice guidelines, which recommend warfarin use based on thromboembolic risk without consideration for CKD status.
Source: Circulation: Cardiovascular Quality and Outcomes - June 2, 2014 Category: Cardiology Authors: Schneider, P. M., Tavel, H. M., Witt, D. M., Kauffman, Y. S., Shetterly, S. M., Go, A. S., Ho, P. M., Magid, D. J. Tags: Session Title: Poster Session II Source Type: research

Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: a systematic review and meta-analysis
Conclusion Our meta-analysis revealed a trend for a reduction of the risk of ischemic stroke in hemodialysis patients with AF treated with VKA. The true protective effect may have been underestimated, owing to inclusion of low-risk patients not expected to benefit from anticoagulation and to suboptimal anticoagulation. However, assessment of the overall effect of VKA in hemodialysis patients should also take into account the increased risk of bleeding, in particular of hemorrhagic stroke. Whether new oral anticoagulants provide a better benefit–risk ratio in hemodialysis patients should be the subject of future trials.
Source: American Heart Journal - October 4, 2016 Category: Cardiology Source Type: research

Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial
Conclusion The majority of deaths occurred in patients who did not experience a non-fatal CV or renal event, although the risk of death was higher following an event. Our findings illustrate continuing opportunities to reduce morbidity and mortality in patients with type 2 diabetes.
Source: European Heart Journal - September 21, 2015 Category: Cardiology Authors: Jhund, P. S., McMurray, J. J. V., Chaturvedi, N., Brunel, P., Desai, A. S., Finn, P. V., Haffner, S. M., Solomon, S. D., Weinrauch, L. A., Claggett, B. L., Pfeffer, M. A. Tags: Prevention and epidemiology Source Type: research

Cardiac surgery outcomes in patients with antecedent kidney, liver, and pancreas transplantation: a meta-analysis.
Authors: Bacusca AE, Enache M, Tarus A, Litcanu CI, Burlacu A, Tinica G Abstract Cardiovascular events are among the most common causes of late death in the transplant recipient (Tx) population. Moreover, major cardiac surgical procedures are more challenging and risky due to immunosuppression and the potential impact on the transplanted organ's functional capacity. We aimed to assess open cardiac surgery safety in abdominal solid organ transplant recipients, comparing the postoperative outcomes with those of nontransplant (N-Tx) patients. Electronic databases of PubMed, EMBASE, and SCOPUS were searched. The endpoi...
Source: Reviews in Cardiovascular Medicine - January 5, 2021 Category: Cardiology Tags: Rev Cardiovasc Med Source Type: research

Chronic Rejection and Atherosclerosis in Post-Transplant Cardiovascular Mortality: Two Sides of the Same Coin
Cardiovascular disease (CVD) as defined by the American Heart Association includes ischaemic heart disease, stroke, heart failure and thromboembolism [1]. Solid organ transplantation is associated with an increased risk of CVD morbidity and mortality [2], a relationship which was first observed in the context of kidney transplantation by Foley in 1998 [3]. This manifests clinically as an increased rate of major adverse cardiovascular events (MACE), defined as the composite of cardiac death, non-fatal myocardial infarction, non-fatal stroke, unstable angina and heart failure [4,5].
Source: Heart, Lung and Circulation - November 27, 2021 Category: Cardiology Authors: Afolarin A. Otunla, Kumaran Shanmugarajah, Maria Lucia Madariaga, Alun H. Davies, Joseph Shalhoub Tags: Editorial Source Type: research

Outcomes of Combined Heart-Kidney Transplantation in Older Recipients
CONCLUSION: Combined HKT is increasing in older recipients, and advanced age ≥65 should not preclude HKT.PMID:37396466 | PMC:PMC10314816 | DOI:10.1155/2023/4528828
Source: Cardiology Research and Practice - July 3, 2023 Category: Cardiology Authors: Curry Sherard Vineeth Sama Jennie H Kwon Khaled Shorbaji Lauren V Huckaby Brett A Welch Chakradhari Inampudi Ryan J Tedford Arman Kilic Source Type: research

Transcatheter aortic valve implantation improves outcome compared to open-heart surgery in kidney transplant recipients requiring aortic valve replacement.
CONCLUSIONS: Based on our center's experience, TAVI appears to be an effective and safe alternative to conventional surgery for AVR in patients with prior renal transplantation. Renal transplantation is not currently identified as a risk factor in our traditional scoring system, and may need to be considered independently when weighing alternatives for AVR. PMID: 23611171 [PubMed - as supplied by publisher]
Source: Journal of Cardiology - April 20, 2013 Category: Cardiology Authors: Fox H, Büttner S, Hemmann K, Asbe-Vollkopf A, Doss M, Beiras-Fernandez A, Moritz A, Zeiher AM, Scheuermann E, Geiger H, Fichtlscherer S, Hauser IA, Lehmann R Tags: J Cardiol Source Type: research

Cardiovascular Risk Assessment Before and After Kidney Transplantation
Cardiovascular disease (CVD) is the leading cause of death in dialysis patients and the most common cause of death and allograft loss among kidney transplant recipients. End-stage renal disease (ESRD) is associated with an increased incidence and prevalence of a wide range of CVDs including coronary artery disease, stroke, congestive heart failure, atrial fibrillation, sudden cardiac death, pulmonary hypertension, and valvular heart disease. CVD risk factors are very common in patients with ESRD, and most patients have multiple risk factors. Kidney transplantation is the treatment of choice for patients with ESRD, as a suc...
Source: Cardiology in Review - June 6, 2014 Category: Cardiology Tags: Review Articles Source Type: research

Hypertensive emergency in kidney transplant recipient with autosomal dominant polycystic kidney disease
We report a case of kidney transplant recipient with autosomal dominant polycystic kidney disease (ADPKD) presenting with diplopia and hypertensive emergency complicated by cerebral aneurysmal rupture.
Source: Journal of the American Society of Hypertension - March 31, 2016 Category: Cardiology Authors: Ekamol Tantisattamo, Attasit Chokechanachaisakul, Siwadon Pitukweerakul, Praveen Ratanasrimetha, Pritika Shrivastava, Dilip Samarapungavan, Shaun P. Healy Tags: Stroke Source Type: research

High dietary salt intake: an overlooked cause of posterior reversible encephalopathy syndrome in kidney transplant recipient with salt-sensitive hypertension
We report a case of kidney transplant recipient with chronic renal allograft dysfunction presenting with posterior reversible encephalopathy syndrom (PRES) secondary to uncontrolled HTN from high dietary Na intake.
Source: Journal of the American Society of Hypertension - March 31, 2016 Category: Cardiology Authors: Ekamol Tantisattamo, Attasit Chokechanachaisakul, Siwadon Pitukweerakul, Praveen Ratanasrimetha Tags: Stroke Source Type: research

Pages: 1  2  3